Hikma Pharmaceuticals PLC (LON:HIK – Get Free Report) reached a new 52-week low on Thursday . The stock traded as low as GBX 4.32 ($0.05) and last traded at GBX 2,134 ($26.27), with a volume of 784546 shares. The stock had previously closed at GBX 2,130 ($26.22).
Hikma Pharmaceuticals Stock Up 0.4 %
The business’s 50 day moving average price is GBX 1,959.25 and its 200-day moving average price is GBX 1,932.89. The company has a debt-to-equity ratio of 55.48, a current ratio of 1.66 and a quick ratio of 1.27. The company has a market cap of £4.74 billion, a P/E ratio of 3,289.23, a PEG ratio of 2.38 and a beta of 0.41.
Hikma Pharmaceuticals Company Profile
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- How to Invest in the Best Canadian Stocks
- 2 ETFs to Maximize Gains With Covered Call Strategies
- 3 Small Caps With Big Return Potential
- 3 Small-Cap Stocks Insiders and Institutions Are Buying
- What is the S&P 500 and How It is Distinct from Other Indexes
- MaxCyte: Building the Future of Cell and Gene Therapy Innovation
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
